Unraveling the mechanism of action of thiazolidinediones.
作者信息
Kahn C R, Chen L, Cohen S E
机构信息
Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA.
出版信息
J Clin Invest. 2000 Dec;106(11):1305-7. doi: 10.1172/JCI11705.
Abstract
摘要
相似文献
1
Unraveling the mechanism of action of thiazolidinediones.
J Clin Invest. 2000 Dec;106(11):1305-7. doi: 10.1172/JCI11705.
2
[Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Duodecim. 1997;113(19):1847-8.
3
Troglitazone.
Compr Ther. 1997 Aug;23(8):560-2.
4
New treatment for adult-onset diabetes.
Nurs Spectr (Wash D C). 1997 Aug 11;7(16):8.
5
[Glitazone--a new class of drugs for the treatment of type 2 diabetes].
Dtsch Med Wochenschr. 2001 Aug 24;126(34-35):951-2. doi: 10.1055/s-2001-16578.
6
[Thiazolidinediones].
Journ Annu Diabetol Hotel Dieu. 1999:213-29.
7
Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
Nurse Pract. 1997 Jul;22(7):119-21.
8
New diabetes drug targets insulin resistance.
Am J Health Syst Pharm. 1997 Mar 15;54(6):623, 625. doi: 10.1093/ajhp/54.6.623.
9
Another potential use of troglitazone in noninsulin-dependent diabetes mellitus.
J Clin Endocrinol Metab. 1998 Mar;83(3):1041-2. doi: 10.1210/jcem.83.3.4668-1.
10
Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther. 1997 May 23;39(1001):49-51.
引用本文的文献
1
Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitization.
Nat Metab. 2024 May;6(5):880-898. doi: 10.1038/s42255-024-01023-w. Epub 2024 Apr 11.
2
Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic.
Medicina (Kaunas). 2023 Oct 11;59(10):1810. doi: 10.3390/medicina59101810.
3
Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure.
Front Clin Diabetes Healthc. 2021 Aug 23;2:731574. doi: 10.3389/fcdhc.2021.731574. eCollection 2021.
4
The Role of PPARs in Breast Cancer.
Cells. 2022 Dec 28;12(1):130. doi: 10.3390/cells12010130.
5
Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes.
Stem Cells Int. 2022 Aug 22;2022:8637493. doi: 10.1155/2022/8637493. eCollection 2022.
6
Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis.
J Diabetes Res. 2022 Feb 18;2022:3846253. doi: 10.1155/2022/3846253. eCollection 2022.
7
Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?
Mol Metab. 2021 Apr;46:101158. doi: 10.1016/j.molmet.2020.101158. Epub 2020 Dec 30.
8
Plasma Cathepsin D Activity Rather Than Levels Correlates With Metabolic Parameters of Type 2 Diabetes in Male Individuals.
Front Endocrinol (Lausanne). 2020 Sep 30;11:575070. doi: 10.3389/fendo.2020.575070. eCollection 2020.
9
Sclerostin-Neutralizing Antibody Treatment Rescues Negative Effects of Rosiglitazone on Mouse Bone Parameters.
J Bone Miner Res. 2021 Jan;36(1):158-169. doi: 10.1002/jbmr.4170. Epub 2020 Sep 23.
10
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).
J Diabetes Res. 2020 Jul 31;2020:3920196. doi: 10.1155/2020/3920196. eCollection 2020.
本文引用的文献
1
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
J Clin Invest. 2000 Nov;106(10):1221-8. doi: 10.1172/JCI11245.
2
Free fatty acids and pathogenesis of type 2 diabetes mellitus.
Trends Endocrinol Metab. 2000 Nov;11(9):351-6. doi: 10.1016/s1043-2760(00)00323-4.
3
Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.
J Clin Invest. 2000 Aug;106(4):467-72. doi: 10.1172/JCI10843.
4
Insights into insulin resistance and type 2 diabetes from knockout mouse models.
J Clin Invest. 2000 Aug;106(4):459-65. doi: 10.1172/JCI10830.
5
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.
Mol Cell. 2000 Jul;6(1):87-97.
6
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.
Ann Intern Med. 2000 Aug 15;133(4):263-74. doi: 10.7326/0003-4819-133-4-200008150-00009.
7
Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes.
Ann N Y Acad Sci. 1999 Nov 18;892:119-26. doi: 10.1111/j.1749-6632.1999.tb07790.x.
8
Transcriptional regulation of adipogenesis.
Genes Dev. 2000 Jun 1;14(11):1293-307.
9
Mechanism of insulin resistance in A-ZIP/F-1 fatless mice.
J Biol Chem. 2000 Mar 24;275(12):8456-60. doi: 10.1074/jbc.275.12.8456.
10
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.
J Clin Invest. 2000 Feb;105(3):271-8. doi: 10.1172/JCI7901.
Zotero 插件